638 related articles for article (PubMed ID: 32822430)
1. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19.
Liu F; Li L; Xu M; Wu J; Luo D; Zhu Y; Li B; Song X; Zhou X
J Clin Virol; 2020 Jun; 127():104370. PubMed ID: 32344321
[TBL] [Abstract][Full Text] [Related]
3. Laboratory findings of COVID-19: a systematic review and meta-analysis.
Zhang ZL; Hou YL; Li DT; Li FZ
Scand J Clin Lab Invest; 2020 Oct; 80(6):441-447. PubMed ID: 32449374
[TBL] [Abstract][Full Text] [Related]
4. Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.
Qin ZJ; Liu L; Sun Q; Li X; Luo JF; Liu JS; Liu D
Medicine (Baltimore); 2020 Aug; 99(35):e21700. PubMed ID: 32871887
[TBL] [Abstract][Full Text] [Related]
5. Correlation analysis between disease severity and clinical and biochemical characteristics of 143 cases of COVID-19 in Wuhan, China: a descriptive study.
Wang D; Li R; Wang J; Jiang Q; Gao C; Yang J; Ge L; Hu Q
BMC Infect Dis; 2020 Jul; 20(1):519. PubMed ID: 32677918
[TBL] [Abstract][Full Text] [Related]
6. Association between D-Dimer levels and mortality in patients with coronavirus disease 2019 (COVID-19): a systematic review and pooled analysis.
Sakka M; Connors JM; Hékimian G; Martin-Toutain I; Crichi B; Colmegna I; Bonnefont-Rousselot D; Farge D; Frere C
J Med Vasc; 2020 Sep; 45(5):268-274. PubMed ID: 32862984
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of initial blood urea nitrogen combined with D-dimer levels for predicting in-hospital mortality in COVID-19 patients.
Cheng A; Hu L; Wang Y; Huang L; Zhao L; Zhang C; Liu X; Xu R; Liu F; Li J; Ye D; Wang T; Lv Y; Liu Q
Int J Antimicrob Agents; 2020 Sep; 56(3):106110. PubMed ID: 32712332
[TBL] [Abstract][Full Text] [Related]
8. Lactate dehydrogenase and C-reactive protein as predictors of respiratory failure in CoVID-19 patients.
Poggiali E; Zaino D; Immovilli P; Rovero L; Losi G; Dacrema A; Nuccetelli M; Vadacca GB; Guidetti D; Vercelli A; Magnacavallo A; Bernardini S; Terracciano C
Clin Chim Acta; 2020 Oct; 509():135-138. PubMed ID: 32531257
[TBL] [Abstract][Full Text] [Related]
9. Role of hematological parameters in COVID-19 patients in the emergency room.
Usul E; Şan İ; Bekgöz B; Şahin A
Biomark Med; 2020 Sep; 14(13):1207-1215. PubMed ID: 32692248
[No Abstract] [Full Text] [Related]
10. Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.
Liao D; Zhou F; Luo L; Xu M; Wang H; Xia J; Gao Y; Cai L; Wang Z; Yin P; Wang Y; Tang L; Deng J; Mei H; Hu Y
Lancet Haematol; 2020 Sep; 7(9):e671-e678. PubMed ID: 32659214
[TBL] [Abstract][Full Text] [Related]
11. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.
An PJ; Zhu YZ; Yang LP
Pharmacol Res; 2020 Sep; 159():104946. PubMed ID: 32450346
[TBL] [Abstract][Full Text] [Related]
12. D-dimer levels on admission and all-cause mortality risk in COVID-19 patients: a meta-analysis.
Simadibrata DM; Lubis AM
Epidemiol Infect; 2020 Sep; 148():e202. PubMed ID: 32892787
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
[No Abstract] [Full Text] [Related]
14. Neutrophil-to-Lymphocyte Ratios Are Closely Associated With the Severity and Course of Non-mild COVID-19.
Qun S; Wang Y; Chen J; Huang X; Guo H; Lu Z; Wang J; Zheng C; Ma Y; Zhu Y; Xia D; Wang Y; He H; Wang Y; Fei M; Yin Y; Zheng M; Xu Y; Ge W; Hu F; Zhou J
Front Immunol; 2020; 11():2160. PubMed ID: 32983180
[TBL] [Abstract][Full Text] [Related]
15. Appropriate use of tocilizumab in COVID-19 infection.
Keske Ş; Tekin S; Sait B; İrkören P; Kapmaz M; Çimen C; Uğur S; Çelebi İ; Bakır VO; Palaoğlu E; Şentürk E; Çağlayan B; Çakar N; Tabak L; Ergönül Ö
Int J Infect Dis; 2020 Oct; 99():338-343. PubMed ID: 32726724
[TBL] [Abstract][Full Text] [Related]
16. Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room.
Assandri R; Buscarini E; Canetta C; Scartabellati A; Viganò G; Montanelli A
Arch Med Res; 2020 Aug; 51(6):598-599. PubMed ID: 32471703
[TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory features of COVID-19: Predictors of severe prognosis.
Bastug A; Bodur H; Erdogan S; Gokcinar D; Kazancioglu S; Kosovali BD; Ozbay BO; Gok G; Turan IO; Yilmaz G; Gonen CC; Yilmaz FM
Int Immunopharmacol; 2020 Nov; 88():106950. PubMed ID: 32919217
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic Findings in Patients With COVID-19 Pneumonia.
Mahmoud-Elsayed HM; Moody WE; Bradlow WM; Khan-Kheil AM; Senior J; Hudsmith LE; Steeds RP
Can J Cardiol; 2020 Aug; 36(8):1203-1207. PubMed ID: 32474111
[TBL] [Abstract][Full Text] [Related]
19. IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19.
Luo M; Liu J; Jiang W; Yue S; Liu H; Wei S
JCI Insight; 2020 Jul; 5(13):. PubMed ID: 32544099
[TBL] [Abstract][Full Text] [Related]
20. Serum Amyloid A is a biomarker of severe Coronavirus Disease and poor prognosis.
Li H; Xiang X; Ren H; Xu L; Zhao L; Chen X; Long H; Wang Q; Wu Q
J Infect; 2020 Jun; 80(6):646-655. PubMed ID: 32277967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
